Document Detail


B-type natriuretic Peptide: application in the community.
MedLine Citation:
PMID:  18772639     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Natriuretic peptide assessment has represented a significant advance in the management of heart failure. In a syndrome in which clinical symptoms and signs can be either nonspecific or absent, the presence of a reliable biomarker to aid diagnosis, assess prognosis, and potentially guide treatment and aid in prevention of this syndrome has represented a significant advance. The following review will outline established and potential new roles for natriuretic peptide assessment in the community.
Authors:
Ken McDonald; Ulf Dahlström; Nadia Aspromonte; Patrick Jourdain; Alan Maisel; Christian Mueller; Roberto Valle
Related Documents :
9509049 - Postpartum problems.
3968299 - Transthoracic electrical impedance as an index of extracellular fluid volume in man.
12585289 - European alchemy: some traditional beliefs.
16489159 - Morbidity and mortality in 928 dobermanns born in the netherlands between 1993 and 1999.
21835589 - Two adults with multiple disabilities use a computer-aided telephone system to make pho...
21379419 - The integration of multiple hiv/aids projects into a coordinated national programme in ...
9391529 - The kock pouch urinary reservoir.
19806489 - Poverty and psychological health among aids-orphaned children in cape town, south africa.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Congestive heart failure (Greenwich, Conn.)     Volume:  14     ISSN:  1527-5299     ISO Abbreviation:  Congest Heart Fail     Publication Date:    2008 Jul-Aug
Date Detail:
Created Date:  2008-09-05     Completed Date:  2008-11-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9714174     Medline TA:  Congest Heart Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  12-6     Citation Subset:  IM    
Affiliation:
St Vincent's University Hospital, Dublin, Ireland. kenneth.mcdonald@ucd.ie
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Heart Failure / diagnosis*,  physiopathology
Humans
Mass Screening
Natriuretic Peptide, Brain / diagnostic use*
Prognosis
Risk Assessment
Risk Factors
Chemical
Reg. No./Substance:
114471-18-0/Natriuretic Peptide, Brain

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Screening for asymptomatic left ventricular dysfunction using B-type natriuretic Peptide.
Next Document:  A comparison of the blood pressure changes of lumiracoxib with those of ibuprofen and naproxen.